June 28, 2024
Neither tirzepatide nor GLP-1 medications are recommended during pregnancy or breastfeeding
Shah Z, Kampfrath T, Deiuliis JA, Zhong J, Pineda C, Ying Z, Xu X, Lu B, Moffatt-Bruce S, Durairaj R, Sun Q, Mihai G, Maiseyeu A, Rajagopalan S (2011) Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis
Likewise, 62.9% of people on semaglutide showed resolution of steatohepatitis without worsening of fibrosis, compared with 34.3% on placebo
Ill also give recommendations for those who are taking or are considering taking them for weight loss
Risk assessment for the amino acids taurine, L-glutamine and L-arginine